Aminopar
 OpenBabel02212023462D

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145   -1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1434    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289    2.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  1  9  1  0  0  0  0
  2  3  1  0  0  0  0
  2  8  1  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4  7  1  0  0  0  0
  5  6  2  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  END
>  <CdId>
1583

>  <Mol Weight>
153.1354

>  <Formula>
C7H7NO3

>  <ID>
T1296

>  <Name>
Aminopar

>  <Synonyms>
para-aminosalicylic acid;Aminosalicylic acid;4-aminosalicylate

>  <CAS>
65-49-6

>  <Approved status>
Other countries

>  <Disease>
Immune system/Endocrine system

>  <Indication>
Tuberculosis; Ulcerative Colitis; Hyperthyroidism

>  <Pathways>
Immunology/Inflammation; Metabolism; NF-¦ªb; Neuroscience

>  <Target>
COX inhibitor; Lipoxygenase; MPO; NF-¦ÊB inhibitor

>  <Receptor>
COX-2; ALOX5; MPO; NF-¦ÊB

$$$$
